BioCentury | May 24, 2004
Strategy

Celltech's path to acquisition

Celltech's path to acquisition Selected events traced against the weekly stock price of Celltech (LSE:CCH; CLL) in pence over the past five years. A.6/15/99Chiroscience merger announced; CCH 6/14/99 Mcap = £364.8M ($591M)B.8/6/99Chiroscience merger completedC.11/11/99Medeva acquisition...
BioCentury | Sep 1, 2003
Strategy

Celltech: Building critical mass

...thing in common - they came almost for free. Fellner described the 2000 acquisition of Cistron Biotechnology Inc....
...E. 3/22/00 - Cistron announcement; CCH 3/21/00 mkt cap = £3.2B ($5B) F. 11/6/00 - Cistron...
BioCentury | Aug 4, 2003
Strategy

Bellwether thinking

...merging with Chiroscience Group plc in 1999, Medeva in 2000, and by acquiring antibody play Cistron Biotechnology Inc....
BioCentury | Jul 14, 2003
Strategy

What's in a name?

...1999, followed in 2000 by the acquisition of Medeva plc . In 2001, CCH acquired Cistron Biotechnology Inc....
BioCentury | Aug 26, 2002
Company News

Cistronics Cell Technology GmbH, Inotech Encapsulation AG other research news

Researchers published in Nature Biotechnology the use of a bacterial erythromycin-resistance regulon to design an inducible mammalian gene regulation system that is responsive to erythromycin, clarithromycin, and roxithromycin. The researchers validated this technology by controlling...
BioCentury | Nov 13, 2000
Company News

Celltech Group, Cistron deal

...Celltech Group plc (LSE:CCH; CLL), Slough, U.K. Cistron Biotechnology Inc. (CIST), Pine Brook, N.J. Business: Autoimmune/Inflammation CCH completed...
BioCentury | Sep 5, 2000
Company News

Celltech Group, Cistron, Aventis deal

...preventive and therapeutic vaccines (see BioCentury, March 27). Celltech Group plc (LSE:CCH; CLL), Slough, U.K. Cistron Biotechnology Inc....
BioCentury | Aug 14, 2000
Company News

University of California other research news

UCLA researchers published in Nature Medicine the development of a reporter system to image gene expression in vivo for use in monitoring gene therapy treatments. In the reporter system, a common promoter directs expression of...
BioCentury | May 22, 2000
Company News

Annovis management update

...Aston, Penn. Business: Neurological Hired: Bruce Galton as president and COO, formerly CEO at Cistron Biotechnology Inc. WIR...
BioCentury | Mar 27, 2000
Company News

Celltech Group, Cistron, Connetics, Lonza Group Ltd. deal

...culture using Lonza's GS System gene expression technology. Celltech Group plc (LSE:CCH; CLL), Slough, U.K. Cistron Biotechnology Inc....
Items per page:
1 - 10 of 41
BioCentury | May 24, 2004
Strategy

Celltech's path to acquisition

Celltech's path to acquisition Selected events traced against the weekly stock price of Celltech (LSE:CCH; CLL) in pence over the past five years. A.6/15/99Chiroscience merger announced; CCH 6/14/99 Mcap = £364.8M ($591M)B.8/6/99Chiroscience merger completedC.11/11/99Medeva acquisition...
BioCentury | Sep 1, 2003
Strategy

Celltech: Building critical mass

...thing in common - they came almost for free. Fellner described the 2000 acquisition of Cistron Biotechnology Inc....
...E. 3/22/00 - Cistron announcement; CCH 3/21/00 mkt cap = £3.2B ($5B) F. 11/6/00 - Cistron...
BioCentury | Aug 4, 2003
Strategy

Bellwether thinking

...merging with Chiroscience Group plc in 1999, Medeva in 2000, and by acquiring antibody play Cistron Biotechnology Inc....
BioCentury | Jul 14, 2003
Strategy

What's in a name?

...1999, followed in 2000 by the acquisition of Medeva plc . In 2001, CCH acquired Cistron Biotechnology Inc....
BioCentury | Aug 26, 2002
Company News

Cistronics Cell Technology GmbH, Inotech Encapsulation AG other research news

Researchers published in Nature Biotechnology the use of a bacterial erythromycin-resistance regulon to design an inducible mammalian gene regulation system that is responsive to erythromycin, clarithromycin, and roxithromycin. The researchers validated this technology by controlling...
BioCentury | Nov 13, 2000
Company News

Celltech Group, Cistron deal

...Celltech Group plc (LSE:CCH; CLL), Slough, U.K. Cistron Biotechnology Inc. (CIST), Pine Brook, N.J. Business: Autoimmune/Inflammation CCH completed...
BioCentury | Sep 5, 2000
Company News

Celltech Group, Cistron, Aventis deal

...preventive and therapeutic vaccines (see BioCentury, March 27). Celltech Group plc (LSE:CCH; CLL), Slough, U.K. Cistron Biotechnology Inc....
BioCentury | Aug 14, 2000
Company News

University of California other research news

UCLA researchers published in Nature Medicine the development of a reporter system to image gene expression in vivo for use in monitoring gene therapy treatments. In the reporter system, a common promoter directs expression of...
BioCentury | May 22, 2000
Company News

Annovis management update

...Aston, Penn. Business: Neurological Hired: Bruce Galton as president and COO, formerly CEO at Cistron Biotechnology Inc. WIR...
BioCentury | Mar 27, 2000
Company News

Celltech Group, Cistron, Connetics, Lonza Group Ltd. deal

...culture using Lonza's GS System gene expression technology. Celltech Group plc (LSE:CCH; CLL), Slough, U.K. Cistron Biotechnology Inc....
Items per page:
1 - 10 of 41